Search clinical trials for: sublingual immunotherapy

Total 4401 results

InnaVirVax

Completed

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

HIV-1 Infection

France
Coeruleus Ltd.

Completed

Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults

Insomnia

Israel
Coeruleus Ltd.

Completed

Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

Healthy

Israel
National Cancer Institute (NCI)

Terminated

Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma

Skin Cancer | Metastatic Melanoma

United States
AcelRx Pharmaceuticals, Inc.

Completed

A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery

Major Upper or Lower Abdominal Surgery

United States
Amgen Research (Munich) GmbH

Completed

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Non-Hodgkin's Lymphoma, Relapsed

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Respiratory Hypersensitivity

Germany
Cambridge University Hospitals NHS Foundation Trust

Completed

Study of Tolerance to Oral Peanut (STOP)

Peanut Allergy

United Kingdom
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
Actelion

Completed

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-1)

Systemic Sclerosis | Ulcers

Canada, United States, Belarus, Hungary, Croatia, Australia, Denmark, Ukraine, Bulgaria, Chile, Colombia, Czech Republic, Finland, Germany, India, Italy, Poland, Russian Federation
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy (AV-M-01)

Allergic Rhinitis Due to Dust Mite

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Laboratorios Leti, S.L.

Completed

To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.

Allergy to Alternaria Fungus

Spain
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION)

Alzheimer's Disease

United States
AcelRx Pharmaceuticals, Inc.

Completed

A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain

Pain | Cancer

United States
CHA University

Completed

Misoprostol Administration Before Operative Hysteroscopy

Endometrial Disorder

Korea, Republic of
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Seagen Inc.

Terminated

A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies

Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin

United States
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

Neoplasms | Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin | Carcinomas

United States
Seagen Inc.

Completed

A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma

Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell

United States
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

Disease, Hodgkin

United States, Canada
Seagen Inc.
Millennium Pharmaceuticals, Inc.

Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin

United States, Germany
INSYS Therapeutics Inc

Completed

Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions

Bioavailability

United States
University of Texas Southwestern Medical Center

Completed

Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy (DCOIT)

Peanut Allergy

United States
University of Alabama at Birmingham

Terminated

Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

Neuroblastoma

United States
Mebiopharm Co., Ltd

Unknown

Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma

Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States, Georgia
Sun Yat-sen University

Unknown

A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Nasopharyngeal Carcinoma | Hepatocellular Carcinoma | Breast Carcinoma

China
Lotus Clinical Research, LLC
iX Biopharma Ltd.

Completed

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

Pain

United States
Turku University Hospital

Completed

Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine

Healthy

Finland
Juan A. Arnaiz

Completed

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD). (PHI-IMD)

HIV

Spain
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
Jichi Medical University
Takara Bio Inc.

Unknown

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Japan
Sun Yat-sen University

Unknown

Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy

Stage III Colon Cancer

China
Bostwick Laboratories
Prostate Institute of America; Community Memorial HealthCenter; HemaCare Corporation

Terminated

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer (CRITICAL)

Prostate Cancer

United States
Cedars-Sinai Medical Center

Completed

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

Glioblastoma | Brain Stem Glioma

United States
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Tonix Pharmaceuticals, Inc.

Completed

Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults

Healthy Adults

Canada
Roger Packer
Children's National Research Institute

Completed

Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

Low-grade Gliomas

United States
Jonathan Spergel
University of Arkansas

Withdrawn

Walnut Oral Immunotherapy for Tree Nut Allergy

Peanut Allergy

United States
University Hospital, Rouen

Completed

Microcirculation in Cardiac Surgery (MICROCARD)

Cardiac Disorder

France
University of Cape Town
Population Health Research Institute

Completed

A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis (IMPI)

Tuberculous Pericarditis

South Africa
United Biomedical
Taipei Veterans General Hospital, Taiwan; Kaohsiung Veterans General Hospital. and other collaborators

Completed

Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults

HIV-1 Infection in Adults

Taiwan
Karolinska Institutet

Completed

Misoprostol for Cervical Priming Prior to Vacuum Aspiration

First Trimester Pregnancy | Surgical Termination of Pregnancy

Sweden
Merck KGaA, Darmstadt, Germany

Completed

EMD 521873 in Advanced Solid Tumors, MTD Finding

Non-Hodgkin Lymphoma

Germany, Switzerland
University Hospital, Rouen

Completed

URO-BCG-4 : Bladder Tumors Immunotherapy

Bladder Cancer

France
Johann Wolfgang Goethe University Hospital

Completed

Regulatory T-cells After Subcutaneous Immunotherapy (RTCAS)

Grass Pollen Allergy | Specific Immunotherapy

Germany
National Cancer Institute (NCI)

Terminated

Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

United States
EMD Serono

Terminated

STRIDE - STimulating Immune Response In aDvanced brEast Cancer (STRIDE)

Breast Cancer

Czech Republic, Korea, Republic of, Russian Federation, South Africa, Germany, Slovakia, Austria, United States, Belgium, Poland, Israel, Australia
German Breast Group

Completed

A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)

Breast Cancer

Germany

Search clinical trials for: sublingual immunotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations